Radiofarmakonkezelések

Radiofarmakonkezelések, also known as radiopharmaceutical therapy, is a medical treatment that uses radioactive drugs to diagnose and treat diseases. These drugs, called radiopharmaceuticals, consist of a radioactive isotope attached to a targeting molecule. The targeting molecule directs the radiopharmaceutical to specific cells or tissues in the body. Once at the target site, the radioactive isotope emits radiation that can be detected by imaging equipment for diagnostic purposes or used to damage or destroy diseased cells for therapeutic purposes.

The application of radiofarmakonkezelések spans both diagnostic imaging and therapeutic interventions. In diagnostics, techniques like Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) utilize radiopharmaceuticals to visualize metabolic processes and identify abnormalities. This aids in the early detection and staging of various conditions, including cancers, neurological disorders, and cardiovascular diseases.

Therapeutically, radiofarmakonkezelések offers a targeted approach to treatment. The radioactive component delivers a localized dose of radiation, minimizing damage to surrounding healthy tissues. This method is particularly effective for certain types of cancer, such as thyroid cancer, prostate cancer, and neuroendocrine tumors. The choice of radiopharmaceutical depends on the specific disease and the targeted cells. Radiofarmakonkezelések is administered intravenously, orally, or injected directly into a tumor. The radioactive isotopes used have short half-lives, meaning their radioactivity decays relatively quickly, reducing the duration of radiation exposure to the patient.